AdvertisementAn FDA panel supports Merck COVID drug in mixed voteNovember 30, 2021Scott HensleyfacebookEmailA COVID-19 antiviral pill called molnupiravir from Merck and Ridgeback Biotherapeutics is being considered by the Food and Drug Administration for emergency use in the coronavirus pandemic. (Merck & Co Inc./Handout via Reuters)